Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Non-Current Deffered Revenue (2017 - 2018)

Cue Biopharma's Non-Current Deffered Revenue history spans 2 years, with the latest figure at $9000.0 for Q1 2018.

  • For Q1 2018, Non-Current Deffered Revenue changed N/A year-over-year to $9000.0; the TTM value through Mar 2018 reached $9000.0, changed N/A, while the annual FY2017 figure was $36000.0, N/A changed from the prior year.
  • Non-Current Deffered Revenue for Q1 2018 was $9000.0 at Cue Biopharma, down from $36000.0 in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $36000.0 in Q4 2017 and bottomed at $9000.0 in Q1 2018.